FDA Grants ODD Status To Zymedi`s ZMA001 For Pulmonary Arterial Hypertension
30 Jul 2024 //
PR NEWSWIRE
First in Human Dosed in Clinical Trial of ZMA001 for Treatment of PAH
07 Feb 2024 //
PR NEWSWIRE
30 Jul 2024 //
PR NEWSWIRE
07 Feb 2024 //
PR NEWSWIRE